FDA clears Elscint entry-level spiral CT

Article

Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last

Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last year's RadiologicalSociety of North America meeting, uses a unique short-geometrydesign to save space. Elscint plans to begin international deliveriesof SeleCT/SP in the third quarter, with U.S. shipments startingin the fourth quarter.

In other SeleCT/SP news, Elscint signed an agreement with BirlaMedical Technologies of India in which BMT will assemble SeleCT/SPunder license for sale in the Indian market. BMT expects to beginassembling SeleCT/SP scanners in a factory near New Delhi laterthis year.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.